BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33626864)

  • 21. How I manage cerebral vasculopathy in children with sickle cell disease.
    Brousse V; Kossorotoff M; de Montalembert M
    Br J Haematol; 2015 Sep; 170(5):615-25. PubMed ID: 25944412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities.
    Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Hau I; Leveillé E; Vasile M; Kasbi F; Madhi F; Fourmaux C; Biscardi S; Gluckman E; Socié G; Dalle JH; Epaud R; Pondarré C
    Blood; 2016 Apr; 127(14):1814-22. PubMed ID: 26851292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle Cell Disease and Stroke.
    Hirtz D; Kirkham FJ
    Pediatr Neurol; 2019 Jun; 95():34-41. PubMed ID: 30948147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
    Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
    Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
    Lefèvre N; Dufour D; Gulbis B; Lê PQ; Heijmans C; Ferster A
    Blood; 2008 Jan; 111(2):963-4; author reply 964. PubMed ID: 18182580
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
    Ghafuri DL; Abdullahi SU; Dambatta AH; Galadanci J; Tabari MA; Bello-Manga H; Idris N; Inuwa H; Tijjani A; Suleiman AA; Jibir BW; Gambo S; Gambo AI; Khalifa Y; Haliru L; Abdulrasheed S; Zakari MA; Greene BC; Trevathan E; Jordan LC; Aliyu MH; Baumann AA; DeBaun MR
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e56-e61. PubMed ID: 34001783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
    Bernaudin F; Verlhac S; Coïc L; Lesprit E; Brugières P; Reinert P
    Pediatr Radiol; 2005 Mar; 35(3):242-8. PubMed ID: 15703901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries.
    Bhattacharya P; Sarmah D; Dave KR; Goswami A; Watanabe M; Wang X; Kalia K; Plesnila N; Yavagal DR; Alvarez O
    J Neurol Sci; 2021 Aug; 427():117510. PubMed ID: 34077859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyurea can be used in children with sickle cell disease and cerebral vasculopathy for the prevention of chronic complications? A meta-analysis.
    Núñez RM; Figueroa CAP; García-Perdomo HA
    J Child Health Care; 2020 Mar; 24(1):64-77. PubMed ID: 30606035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE;
    Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 36. Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10-year longitudinal study on the SPPIBA cohort.
    Lagunju IA; Labaeka A; Ibeh JN; Orimadegun AE; Brown BJ; Sodeinde OO
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28906. PubMed ID: 33522690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New issues in adult sickle sell disease].
    Girot R; Stankovic K; Lionnet F
    Bull Acad Natl Med; 2008 Oct; 192(7):1395-409; discussion 1409-11. PubMed ID: 19445365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?
    Bernaudin F
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):121-130. PubMed ID: 32202243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.
    Abdullahi SU; DeBaun MR; Jordan LC; Rodeghier M; Galadanci NA
    Pediatr Neurol; 2019 Jun; 95():73-78. PubMed ID: 30952488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.